Accuray (NSDQ:ARAY) shares were slightly down after hours today on first-quarter results that beat the consensus forecast. The Sunnyvale, California-based radiation oncology company posted losses of $1 million, or 1¢ per share, on sales of $107.4 million for the three months ended Sept. 30, 2021, seeing its bottom line slide into the red despite sales […]
Accuray Inc.
Accuray beats The Street in Q4
Accuray (NSDQ:ARAY) shares dipped this morning despite fourth-quarter results that beat the consensus forecast. The Sunnyvale, Calif.-based radiation oncology company posted losses of -$11.1 million, or -12¢ per share, on sales of $110.9 million for the three months ended June 30, 2021, for a massive bottom-line slide from losses of $152,000 this time last year […]
Accuray promotes exec Suzanne Winter to president
Accuray (NSDQ:ARAY) announced that it promoted executive Suzanne Winter to president, effective as of July 1, 2021. Winter, who previously served as Sunnyvale, Calif.-based Accuray’s chief commercial officer and SVP of R&D & medical & scientific affairs, will continue to report to CEO Joshua Levine. “Suzanne has had a significant impact on Accuray’s product portfolio […]
Accuray names chief medical, technology officer
Accuray (NSDQ:ARAY) today said it has appointed Dr. Jean-Philippe Pignol as its chief medical and technology officer, effective April 15. Pignol will lead the company’s scientific and clinical research activities, develop strategic collaborations, evaluate new technologies and serve as the representative with important industry partners. “We’re thrilled to welcome Dr. Pignol, whose rich and unique […]
Accuray beats The Street in Q2 earnings
Accuray (NSDQ:ARAY) yesterday posted second-quarter results that beat the consensus forecast on Wall Street. The Sunnyvale, Calif.-based radiation oncology company reported profits of $4.8 million, or 5¢ per share, on sales of $97.5 million for the three months ended Dec. 31, 2020, for a bottom-line slide of -55.5% sales loss of -1.4% compared with Q2 2020. […]
Accuray ticks up on Street-beating Q1
Accuray (NSDQ:ARAY) shares ticked up today on first-quarter results that came in ahead of the consensus forecast. The Sunnyvale, Calif.-based radiotherapy device maker posted profits of $402,000, breaking even on a per-share basis, on sales of $85.3 million for the three months ended Sept. 30, 2020, for a bottom-line gain from losses of more than -$9.3 […]
Accuray dips on mixed bag Q4
Accuray (NSDQ:ARAY) shares took a hit today on fourth-quarter results that were mixed compared to the consensus forecast. The Sunnyvale, Calif.-based radiotherapy device maker posted losses of -$823,000, or -1¢ per share, on sales of $94.98 million for the three months ended June 30, 2020, for a 41.2% bottom-line gain on a sales decline of -19.1%. […]
Accuray launches CyberKnife S7 system
Accuray (NSDQ:ARAY) announced today that it launched its CyberKnife S7 system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Using real-time artificial intelligence-driven motion tracking and synchronization, CyberKnife S7 offers treatments for SRS and SBRT in as little as 15 minutes, according to a news release. The system’s AI adapts radiation delivery to patient […]
Accuray beats The Street in Q3 results
Accuray posted third-quarter results that beat the consensus forecast on Wall Street but lowered its financial guidance for 2020. The Sunnyvale, Calif.-based company reported profits of $2.6 million, or 3¢ per share, on sales of $99.5 million for the three months ended March 31, for a bottom-line loss of -93.5% sales loss of -3.6% compared […]
Accuray beats The Street on earnings and revenue in Q2 results
Accuray (NSDQ:ARAY) posted second-quarter results that beat the consensus forecast on Wall Street. The Sunnyvale, Calif.-based company reported profits of $10.7 million, or 12¢ per share, on sales $98.8 million for three months ended Dec. 31, 2019 for a sales loss of -48.6% compared with Q2 2019. Adjusted to exclude one-time items, earnings per share were […]
Accuray shares drop as bottom line, revenues slide
Accuray (NSDQ:ARAY) shares are down today after the company reported decreased sales and profits in the first quarter of fiscal 2020. The Sunnyvale, Calif.-based radiotherapy device maker posted losses of -$9.4 million, or -11¢ per share, on sales of $89.6 million for the three months ended Sept. 30, for a bottom-line slide of -13% on a […]
